The role of TNFα and IL-6 as master regulators of tumor-associated inflammation and tumor-promoting functions makes them promising targets for adjuvant anti-cancer therapy (Yan et al., 2006; Grivennikov and Karin, 2011). The gene discussed is IL6; the disease is cancer.